Harvard Bioscience (HBIO) Free Cash Flow (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Free Cash Flow of -$1.1 million for Q1 2026, down 144.0% year-over-year from $2.5 million in Q1 2025, and down 99.63% quarter-over-quarter from -$545000.0 in Q4 2025.
Harvard Bioscience (HBIO) Free Cash Flow (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Free Cash Flow for 17 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 144.0% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at $1.9 million (up 273.78% YoY), while the FY2025 annual figure was $5.5 million, up 554.4% from the prior year.
- Free Cash Flow fell to -$1.1 million in Q1 2026 per HBIO's latest filing, from -$545000.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $4.1 million in Q3 2023 and bottomed at -$2.5 million in Q1 2022.
- Historically, Free Cash Flow has averaged $881235.3 across 5 years, with a median of $877000.0 in 2025.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 377.31% — and 2023, when it soared 1901.93%.
- Harvard Bioscience's Free Cash Flow stood at $2.4 million in 2022, then jumped by 42.1% to $3.5 million in 2023, then plunged by 59.0% to $1.4 million in 2024, then slumped by 138.27% to -$545000.0 in 2025, then tumbled by 99.63% to -$1.1 million in 2026.
- Business Quant data shows HBIO's Free Cash Flow at -$1.1 million in Q1 2026, -$545000.0 in Q4 2025, and $877000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 948.40 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 633.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 136.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 403.50 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 604.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 80.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 144.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 96.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 181.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -363,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -363,000.00 |
| Jun 30, 2026 | -363,000.00 |
| Mar 31, 2026 | -1.09 Mn |
| Mar 31, 2026 | -1.09 Mn |
| Dec 31, 2025 | -545,000.00 |
| Dec 31, 2025 | -545,000.00 |
| Sep 30, 2025 | 877,000.00 |
| Sep 30, 2025 | 877,000.00 |
| Jun 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -1.72 Mn |
| Sep 30, 2024 | -1.72 Mn |
| Jun 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | -1.66 Mn |
| Mar 31, 2024 | 758,000.00 |
| Mar 31, 2024 | 758,000.00 |